. 2019 Feb 21;9:2440. doi: 10.1038/s41598-019-38977-x

Table 2.

Effect of dihydrohaemanthamine and derivatives of haemanthamine and dihydrohaemanthamine (added at 0.5 and 1 g/L) on total (mM) and individual (% of total VFA) after 24 h of incubation.

	Total VFA (mM)			Acetate (%)			Propionate (%)			Butyrate (%)			BCVFA (%)
	Dose (g/L)			Dose (g/L)			Dose (g/L)			Dose (g/L)			Dose (g/L)
	0	0.5	1	0	0.5	1	0	0.5	1	0	0.5	1	0	0.5	1
Haemanthamine derivatives
2	62.9^a	50.7^b	46.7^b	58.8^a	48.0^b	47.4^b	16.4^a	24.6^b	23.8^b	18.5^a	21.3^a	22.3^a	2.70^a	2.56^a	2.56^a
3	62.9^a	52.1^ab	49.0^b	58.8^a	47.3^b	42.9^b	16.4^a	23.3^b	25.0^b	18.5^a	22.8^ab	25.8^b	2.70^a	2.68^a	2.55^a
4	62.9^a	55.6^a	52.5^a	58.8^a	48.7^b	46.0^b	16.4^a	23.2^b	23.9^b	18.5^a	21.9^ab	23.6^b	2.70^a	2.49^a	2.41^a
5	62.9^a	51.7^a	53.3^a	58.8^a	48.3^b	46.6^b	16.4^a	23.3^b	23.6^b	18.5^a	21.2^a	22.2^a	2.70^a	2.79^a	2.52^a
Dihydrohaemanthamine derivatives
6	62.9^a	57.7^a	52.6^a	58.8^a	56.4^a	55.5^a	16.4^a	19.8^a	20.2^a	18.5^a	17.8^a	18.3^a	2.70^a	2.46^a	2.48^a
7	62.9^a	51.1^b	49.5^b	58.8^a	49.0^b	47.5^b	16.4^a	25.0^b	24.5^b	18.5^a	19.7^a	21.8^a	2.70^a	2.64^a	2.45^a
8	62.9^a	51.4^b	46.9^b	58.8^a	45.5^b	36.8^c	16.4^a	24.0^b	26.9^b	18.5^a	24.0^b	29.2^b	2.70^a	2.58^a	2.05^b
9	62.9^a	51.3^b	55.6^ab	58.8^a	44.6^b	41.6^b	16.4^a	26.2^b	33.9^c	18.5^a	22.0^a	17.0^a	2.70^a	3.27^b	4.18^c
10	62.9^a	55.6^a	62.3^a	58.8^a	41.3^b	41.2^b	16.4^a	27.2^b	37.9^c	18.5^a	22.3^a	10.5^b	2.70^a	2.28^ab	2.05^b
		SED	P		SED	P		SED	P		SED	P		SED	P
Treatment		1.630	0.001		1.110	<0.001		0.572	<0.001		0.643	<0.001		0.061	<0.001
Dose		0.943	<0.001		0.638	<0.001		0.330	<0.001		0.371	<0.001		0.035	0.004
Treatment x Dose		2.830	0.023		1.910	<0.001		0.991	<0.001		1.110	<0.001		0.106	<0.001

VFA: volatile fatty acids; BCVFA: branched chain volatile fatty acids; SED: Standard error of the difference. ^a-bMeans with different superscript differ significantly by dose within treatment.